Antimicrobial susceptibility and association with serotypes of Streptococcus pneumoniae isolates in children with acute otitis media and acute sinusitis in Belarus | CMAC

Antimicrobial susceptibility and association with serotypes of Streptococcus pneumoniae isolates in children with acute otitis media and acute sinusitis in Belarus

Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):206-215

​ Davydov A.V., Titov L.P., Klyuiko N.L., Gurinovich V.V., Lazarev A.V.
10.36488//cmac.2018.3.206-215
pneumococcus Streptococcus pneumoniae children acute otitis media acute bacterial rhinosinusitis resistance serotype
Section
Antimicrobial Resistance
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):206-215

Objective.

To study antibiotic resistance and its association with serotypes of Streptococcus pneumoniae isolated from hospitalized children with community-acquired ENT infections in Belarus during 2013-2016 and to analyze a potential for the use of different antibiotic classes in the treatment of those infections.

Materials and Methods.

A total of 115 strains isolated from children with acute otitis media and 18 strains isolated from children with acute rhinosinusitis were tested. Antimicrobial susceptibility testing was performed by a broth microdilution method. Antimicrobial susceptibility testing results were interpreted according to the CLSI 2017 and EUCAST 2017 criteria.

Results.

Pneumococcal isolates obtained from the children with acute otitis media have the high rates (5074%) of non-susceptibility to the majority of beta-lactams, 14-/15-/16-membered macrolides, lincosamides, tetracyclines, folate pathway inhibitors. Rates of non-susceptible to benzylpenicillin, amoxicillin, III-IV generation cephalosporins, and ertapenem isolates were 37-39%. All tested pneumococcal isolates were fully susceptible to fluoroquinolones, ansamycins, glycopeptides, and oxazolidinones. Wild-type strains were rare (13%). MDR and XDR strains were found in 71% and 38% of children, respectively, and belonged to vaccine serotypes, i.e. were fully covered by PCV13 and PPSV23, but partly covered by PCV10 (84% MDR and 80% XDR strains). Pneumococcal isolates from children with acute rhinosinusitis had lower antimicrobial resistance rates and incidence rates of MDR and XDR strains. It can be explained by different serotype distribution in different age-group patients with different types of infection. There were found associations between a patient’s age <5 years, “pediatric” serotype, and risk for antibiotic resistant pneumococcal infection.

Alexander V. Davydov

Belarusian State Medical University, Minsk, Belarus
Republic Research Center for Epidemiology and Microbiology, Minsk, Belarus

Titov L.P.

Republic Research Center for Epidemiology and Microbiology, Minsk, Belarus

Klyuiko N.L.

Children's City Infectious Diseases Clinical Hospital, Minsk, Belarus

Gurinovich V.V.

Children's City Infectious Diseases Clinical Hospital, Minsk, Belarus

Lazarev A.V.

Children's City Infectious Diseases Clinical Hospital, Minsk, Belarus

  • 1. Rovers M.M. The burden of otitis media. Vaccine. 2008;26(Suppl 7):G2-4.
  • 2. Chonmaitree T., Revai K., Grady J.J., et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis. 2008;46(6):815-823.
  • 3. Teele D.W., Klein J.O., Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160(1):83-94.
  • 4. Kozlov R.S., Muravyev A.A., Scherbakov M.E., et al. Study to assess incidence of acute otitis media in children under 5 years of age in Russia (PAPIRUS-AOM). Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2017;19(2):116-120. Russian.
  • 5. Vergison A., Dagan R., Arguedas A., et al. Otitis media and its consequences: beyond the earache. Lancet Infect Dis. 2010;10(3):195-203.
  • 6. Monasta L., Ronfani L., Marchetti F., et al. Burden of Disease Caused by Otitis Media: Systematic Review and Global Estimates. PLoS ONE. 2012;7(4):e36226.
  • 7. Usonis V., Jackowska T., Petraitiene S., et al. Incidence of acute otitis media in children below 6 years of age seen in medical practices in five East European countries. BMC Pediatr. 2016;16:108.
  • 8. Casey J.R., Kaur R., Friedel V.C., Pichichero M.E. Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York. Pediatr Infect Dis J. 2013;32(8):805-809.
  • 9. Jacobs M.R., Dagan R., Appelbaum P.C., Burch D.J. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother. 1998;42(3):589-595.
  • 10. Rodgers G.L., Arguedas A., Cohen R., Dagan R. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines. Vaccine. 2009;27(29):3802-3810.
  • 11. Chow A.W., Benninger M.S., Brook I., et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54(8):e72-112.
  • 12. Piccirillo J.F. Acute bacterial sinusitis. N Engl J Med. 2004;351(9):902910.
  • 13. American Academy of Pediatrics. Clinical practice guideline: management of sinusitis. Pediatrics. 2001;108(3):798-808.
  • 14. Lindstrand A., Bennet R., Galanis I., et al. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine. Pediatrics. 2014;134(6):e1528-1536.
  • 15. Pichichero M.E., Casey J.R. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298(15):1772-1778.
  • 16. Lieberthal A.S., Carroll A.E., Chonmaitree T., et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964999.
  • 17. Poole M.D. Acute bacterial rhinosinusitis: clinical impact of resistance and susceptibility. Am J Med. 2004;117(Suppl 3A):29S–38S.
  • 18. Tamir S.O., Sibbald A., Rupa V., et al. Guidelines for the Treatment of Acute Otitis Media: Why Are There Worldwide Differences? Curr Otorhinolaryngol Rep. 2017;5(2):101-107.
  • 19. Ovnat Tamir S., Shemesh S., Oron Y., Marom T. Acute otitis media guidelines in selected developed and developing countries: uniformity and diversity. Arch Dis Child. 2017;102(5):450-457.
  • 20. World Health Organization, Centers for Disease Control and Prevention. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae: WHO manual, 2nd ed. Available at: www.who.int/iris/handle/10665/70765. Accessed 22.11.2016.
  • 21. Davydov A.V., Titov L.P., Klyuiko N.L., Gurinovich V.V. Serotypic characteristic of Streptococcus pneumoniae strains isolated from children with acute otitis media and sinusitis. Zdravoohranenie. 2016;(3):12-20. Russian.
  • 22. Davydov A.V., Titov L.P., Kharkhal A.N. The usage of multiplex PCR for serogenotyping the strains of Streptococcus pneumoniae as a part of the monitoring for pneumococcal infection in Belarus. Molecular diagnostics: proceedings collection of IX Russian scientific-practical conference with international participation, Moscow, 18-20 April 2017. Tambov; 2017. pp. 336-338. Russian.
  • 23. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard – 10th edition. CLSI document M07-A10. Wayne, PA: Clinical and Laboratory Standards Institute; 2015. 94 p.
  • 24. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100. 27th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2017. 224 p.
  • 25. Silley P. Susceptibility testing methods, resistance and breakpoints: what do these terms really mean? Rev Sci Tech Int Off Epizoot. 2012;31(1):33-41.
  • 26. The European Committee on Antimicrobial Susceptibility Testing. Antimicrobial wild type distributions of microorganisms [Internet]. Available at: https://mic.eucast.org. Accessed 02.12.2017.
  • 27. Whitney C.G., Farley M.M., Hadler J., et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343(26):1917-1924.
  • 28. Magiorakos A.P., Srinivasan A., Carey R.B., et al. Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-281.
  • 29. Jacobs M.R., Koornhof H.J., Robins-Browne R.M., et al. Emergence of multiply resistant pneumococci. N Engl J Med. 1978;299(14):735740.
  • 30. Golden A.R., Rosenthal M., Fultz B., et al. Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13. J Antimicrob Chemother. 2015;70(8):2199-2202.
  • 31. Hamilton-Miller J.M. Calculating MIC50. J Antimicrob Chemother. 1991;27(6):863-864.
  • 32. Davydov A.V., Titov L.P., Kharkhal A.N., et al. Antibiotic susceptibility of Streptococcus pneumoniae strains isolated from patients with meningitis in Belarus. Zdravoohranenie. 2018;(1):22-32. Russian.
  • 33. Davydov A.V., Titov L.P., Klyuiko N.L., et al. Antimicrobial susceptibility of Streptococcus pneumoniae strains isolated from patients with pneumonia in Belarus. Meditsinskie Novosti. 2017;(12):74-82. Russian.
  • 34. El Moujaber G., Osman M., Rafei R., Dabboussi F., Hamze M. Molecular mechanisms and epidemiology of resistance in Streptococcus pneumoniae in the Middle East region. J Med Microbiol. 2017;66(7):847-858.
  • 35. Song J.-H., Jung S.-I., Ko K.S., et al. High Prevalence of Antimicrobial Resistance among Clinical Streptococcus pneumoniae Isolates in Asia (an ANSORP Study). Antimicrob Agents Chemother. 2004;48(6):2101-2107.
  • 36. Song J.-H., Lee N.Y., Ichiyama S., et al. Spread of Drug-Resistant Streptococcus pneumoniae in Asian Countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis. 1999;28(6):1206-1211.
  • 37. Cornick J.E., Bentley S.D. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides. Microbes Infect. 2012;14(7):573-583.
  • 38. Kim L., McGee L., Tomczyk S., Beall B. Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Preand Post-Conjugate Vaccine Eras: a United States Perspective. Clin Microbiol Rev. 2016;29(3):525-552.
  • 39. Bochkareva N.A., Vasilevski I.V., Titov L.P. Sensitivity/resistance of major pathogenic in acute purulent sinusitis and acute purulent otitis in children and antibacterial therapy they. Meditsinskaya Panorama. 2012;(2):22-27. Russian.
  • 40. Mayanskiy N.A., Alyabieva N.M., Lazareva M.A., et al. Antimicrobial Susceptibility, Clonal and Serotype Diversity of Streptococcus pneumoniae Isolated from Children with Acute Otitis Media in Moscow. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2016;18(2):84-92. Russian.
  • 41. Feikin D.R., Klugman K.P., Facklam R.R., et al. Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin Infect Dis. 2005;41(4):481-487.
  • 42. Olarte L., Hulten K.G., Lamberth L., Mason E.O., Kaplan S.L. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J. 2014;33(10):1033-1036.
  • 43. Germanenko I.G., Tomasheva T.L., Lisitskaya T.I., et al. Pneumococcal infection in children. Zdravoohranenie. 2010;(1):11-14. Russian.
  • 44. Fokkens W.J., Lund V.J., Mullol J., et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;23:1298.
  • 45. Granath A. Recurrent Acute Otitis Media: What Are the Options for Treatment and Prevention? Curr Otorhinolaryngol Rep. 2017;5(2):93100.
  • 46. Wald E.R., Applegate K.E., Bordley C., et al. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013;132(1):e262-280.
  • 47. Rosenfeld R.M., Shin J.J., Schwartz S.R., et al. Clinical Practice Guideline: Otitis Media with Effusion Executive Summary (Update). Otolaryngol-Head Neck Surg. 2016;154(2):201-214.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared